BioLife announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier 1…
Led by a cross functional team of technologists, business leaders, advisors, partners and domain experts, BioLife specializes in moving innovative products from the lab or small scale production into wider market adoption. Â
BioLife announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier 1…
BioLife announced today the launch of Copper Infused Gardening Gloves. These Copper Infused Gardening Gloves are the Company’s latest addition to their…
BioLife is pleased to announce that it is now going to offer non-psychoactive cannabinoid products derived from industrial hemp including CBD products.
Supported by a deep network of relationships spanning: supply chain, regulatory, product development, R&D, IP, finance, sales & distribution
BioLife works with leading companies to move products from the lab or small scale production into wider market adoption
Supported by a deep network of relationships spanning: supply chain, regulatory, product development, R&D, IP, finance, sales & distribution
Sign Up
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.Â
Copyright © 2022 BioLife Sciences Inc. All Rights Reserved.
